OBJECTIVE: There have been hypotheses that early life adiposity gain may influence blood pressure (BP) later in life. We examined associations between timing of height, body mass index (BMI) and adiposity gains in early life with BP at 48 months in an Asian pregnancy-birth cohort. METHODS: In 719 children, velocities for height, BMI and abdominal circumference (AC) were calculated at five intervals [0-3, 3-12, 12-24, 24-36 and 36-48 months]. Triceps (TS) and subscapular skinfold (SS) velocities were calculated between 0-18, 18-36 and 36-48 months. Systolic (SBP) and diastolic blood pressure (DBP) was measured at 48 months. Growth velocities at later periods were adjusted for growth velocities in preceding intervals, as well as measurements at birth. RESULTS: After adjusting for confounders and child height at BP measurement, each unit z-score gain in BMI, AC, TS and SS velocities at 36-48 months were associated with 2.3 (95% CI:1.6, 3.1), 2.1 (1.3, 2.8), 1.4 (0.6, 2.2) and 1.8 (1, 2.6) mmHg higher SBP respectively, and 0.9 (0.4, 1.4), 0.9 (0.4, 1.3), 0.6 (0.1, 1.1) and 0.8 (0.3, 1.3) mmHg higher DBP respectively. BMI and adiposity velocities (AC, TS or SS) at various intervals in the first 36 months however, were not associated with BP. Faster BMI, AC, TS and SS velocities, but not height, at 36-48 months were associated with 0.22 (0.15, 0.29), 0.17 (0.10, 0.24), 0.11 (0.04, 0.19) and 0.15 (0.08, 0.23) units higher SBP z-score respectively, and OR = 1.46 (95% CI: 1.13-1.90), 1.49 (1.17-1.92), 1.45 (1.09-1.92) and 1.43 (1.09, 1.88) times higher risk of prehypertension/hypertension respectively at 48 months. CONCLUSIONS: Our results indicated that faster BMI and adiposity (AC, TS or SS) velocities only at the preceding interval before 48 months (36-48 months), but not at earlier intervals in the first 36 months, are predictive of BP and prehypertension/ hypertension at 48 months.
INTRODUCTION
Non-communicable diseases (NCDs) have been identified as the leading global cause of death, with 63% of deaths attributable to NCDs such as cardiovascular disease (CVD) and diabetes. 1 As projected NCD rates continue to rise worldwide, their burden is rising across all income groups. 2 Raised blood pressure (BP) has been estimated to cause about 12.8% of all NCD-related deaths. 1 More recently, the prevalence of prehypertension and hypertension has also increased markedly among children and adolescents. 3 Given that high BP in childhood is a risk factor for later CVD, 4, 5 insights into its early life risk factors are important for developing preventive strategies to reduce the premature mortality associated with hypertension and CVD.
Many observational studies have linked rapid postnatal weight gain with increased risk of later CVD and metabolic syndrome, in line with the 'growth acceleration hypothesis' proposed by Singhal et al. 6 The hypothesis postulated that faster weight gain during early infancy may adversely program components of metabolic syndrome, including hypertension, suggesting that rapid postnatal weight gain may increase BP later in life. During critical periods of the early life course, accelerated weight gain may increase later BP and CVD risk. Rapid increases in weight and height in the first few months of life have been associated with higher systolic BP in early childhood, 7-10 adolescence 11 and adulthood. 12, 13 Recent cohort studies in Belarus, the United Kingdom and the United States, however, have shown associations between faster weight gain during early childhood (between 1 and 5 years) and higher BP, 9, 10, 14 with stronger effect sizes observed closer to the age of BP measurement.
The current literature linking timing of postnatal weight or adiposity gain with childhood BP is based primarily on Western populations. [7] [8] [9] [10] [11] 13, 14 To our knowledge, only one study 12 has examined the timing of postnatal weight gain in relation to later BP in Asian populations, despite their higher risk of metabolic disease. 15 We therefore examined the associations between gains in height, BMI and adiposity in infancy and early childhood and later BP in an Asian birth cohort, the Growing Up in Singapore Towards healthy Outcomes (GUSTO) study. 1 
METHODS

Study population
The GUSTO study has been previously described in detail. 16, 17 Briefly, pregnant women in their first trimester were recruited from two major public hospitals in Singapore with obstetric services (KK Women's and Children's Hospital and the National University Hospital) between June 2009 and September 2010. Eligible women were Singapore citizens or permanent residents who were of Chinese, Malay or Indian ethnicity with homogeneous parental ethnic backgrounds (mother and father of infant). Women receiving chemotherapy, taking psychotropic drugs or with diabetes mellitus were excluded. Of 3751 screened women, 2034 mothers met these criteria, of whom 1247 (response rate: 61.3%) were recruited and 1170 had singleton deliveries (Figure 1 ). The women gave informed consent to participate in the study, which was approved by both the National Healthcare Group Domain Specific Review Board and the SingHealth Centralized Institutional Review Board.
Antenatal data
Socio-demographic data (age, ethnicity (self-reported), education level and parity) were obtained at recruitment, Gestational age (GA) was assessed at the first ultrasound dating scan during recruitment. Scans were conducted in a standard manner at both hospitals by trained ultrasonographers, with GA reported in completed weeks. At 26-28 weeks of gestation, maternal weight and height were measured with the use of SECA 803 Weighing Scale (SECA Corp, Hamburg, Germany) and SECA 213 Stadiometer (SECA Corp.), respectively. Maternal body mass index (BMI) was calculated as weight divided by the square of height.
Infant anthropometry measurements
All anthropometric measurements were obtained using standardized protocols. 18 Measurements of child weight, length/height and abdominal circumference (AC) were obtained at birth and at 3, 6, 9, 12, 15, 18, 24, 36 and 48 months of age. Weight was measured to the nearest gram using calibrated scales (SECA 334 Weighing Scale (birth to 18 months) and SECA 803 Weighing Scale (24 to 48 months)). Recumbent length (from birth to 24 months) was measured from the top of the head to soles of feet using an infant mat (SECA 210 Mobile Measuring Mat) to the nearest 0.1 cm. Standing height (at 24-48 months) was measured using a stadiometer (SECA stadiometer 213) from the top of participant's head to his or her heels. Both measures of recumbent length and standing height were obtained the 24-month visit, even for infants who were seen before or after 24 months. AC was recorded to the nearest 0.1 cm, using a nonstretchable measuring tape (SECA 212 Measuring Tape, SECA Corp.). For reliability, all measurements were taken in duplicates and averaged.
Body mass index (BMI) at each age was calculated by weight divided by the square of length or height.
Triceps (TS) and subscapular (SS) skinfold thicknesses were measured at birth and at 18-, 24-, 36-and 48-months in triplicates using Holtain skinfold calipers (Holtain Ltd, Crymych, UK) on the right side of the body, recorded to the nearest 0.2 mm. Anthropometric training and standardization sessions were conducted quarterly (once every 3 months), and observers were trained to obtain anthropometric measurements that, on average, were closest to the values measured by a master anthropometrist. Assessment of reliability was estimated by inter-observer technical error of measurement (TE) and coefficient of variation (CV; Supplementary Table 1) . 19 In addition, the TE and CV of the various anthropometric measures do not suggest a larger error at ages below 24 months (Supplementary Table 2 ). As the TE for length and height at age 24 months showed no differences between length (0.01 cm) and height (0.01 cm) (Supplementary Table 2 ), we utilized measures of recumbent length at age 24 months for the analyses reported in this paper.
Blood pressure measurements
Based on a standardized protocol, 20 maternal BP at 26-28 weeks of gestation was taken by trained research coordinators. Mothers rested for at least 10 min before BP measurement, and the peripheral systolic (SBP) and diastolic BP (DBP) were measured thrice from the upper arm at 30-60 s intervals with an oscillometric device (MC3100, HealthSTATS International Pte Ltd, Singapore). An average of the three readings was calculated if the difference between readings was o10 mm Hg; otherwise, measurements were repeated.
Child BP was measured by trained research personnel during the clinic visits. The child was required to sit with the mother for at least 5 min in a quiet room. Peripheral SBP and DBP were measured twice from the right upper arm using a Dinamap CARESCAPE V100 (GE Healthcare, Milwaukee, WI), with the arm resting at the chest level. An average of both BP readings was calculated if the difference between readings was o 10 mm Hg; otherwise, the third reading was taken and the average of the three readings used instead. The decision to use this method of BP measurement in children was made a priori during development of the study protocol. It was chosen over manual measurement of BP because of its ease of use in young children and its applicability when a number of research personnel take the measurements. The feasibility and validity of using the Dinamap device for blood pressure measurement in young children has been demonstrated before in other cohort studies. 21, 22 Prehypertension/hypertension was defined as SBP or DBP above the 90th percentile for the child's sex, age and height. BP z-scores were calculated based on age-, sex-and height-specific reference values published by the American Academy of Pediatrics. 23 As there is currently no reference for blood pressure percentiles in the Singapore population, we utilized the U.S reference values published by the American Academy of Pediatrics.
Statistical analysis
Descriptive statistics are reported as means and standard deviations for continuous variables and percentages for categorical variables. Height, BMI and AC velocities were analyzed as rate of change per month across five intervals (0-3, 3-12, 12-24, 24-36 and 36-48 months). Skinfold thickness (TS or SS) gain velocities were analyzed as rate of change per month across 0-18, 18-36 and 36-48 months. Birth anthropometry and growth velocities were standardized to z-scores within the study cohort to allow direct comparison of effect estimates across different time intervals.
Multivariable linear regression was used to analyze associations between birth anthropometry and growth velocities with child BP at 48 months, adjusting for the following potential confounders: maternal age, parity, education level, height and BMI at 26-28 weeks of gestation, ethnicity, BP and child sex. The child's exact age at the 48-month visit was also included as a covariate to improve precision. Given their tendency to track over time, growth velocities at later periods were additionally adjusted for growth velocities in preceding intervals (that is, conditional on earlier time intervals). The adjusted estimates reflect how an individual child deviates from his or her own previous growth trajectory. The main advantage of this approach is that growth during a given interval is analyzed independently from the earlier growth trajectory. 24 The correlations for each growth velocity variable at different intervals with measured height at 48 months is presented in Supplementary Table 3 , with all correlations (except for height gain velocities) being o 0.20. As height is a strong determinant of Figure 1 . GUSTO recruitment chart and eventual study sample.
childhood BP, 25, 26 all analyses (except for those involving height gain velocities) included height at age 48 months as a covariate. The analyses were also repeated using age-, sex-and height-specific BP z-scores as the outcome.
Multivariable logistic regression was used to analyze associations between birth anthropometry and growth velocities with prehypertension/hypertension risk at 48 months, adjusting for ethnicity, maternal age, parity, education level, height, BMI and BP at 26-28 weeks gestation. Potential effect modification by birth weight-for-GA, sex and ethnicity were investigated by adding interaction terms with the growth variables to the fully-adjusted model. Sensitivity analyses were conducted to assess the robustness of our findings, by determining age-and sex-specific z-scores for height, BMI, triceps and subscapular skinfolds using the World Health Organization (WHO) Child Growth Standards, 27 while z-scores for AC were calculated internally using the GUSTO cohort. We then re-ran the analyses with child BP, BP z-score and prehypertension/hypertension as outcomes, using the z-score velocities across the same intervals as the exposure variable. Multiple imputation was used to account for missing values of maternal height (n = 15), BMI (n = 23), education level (n = 4), SBP and DBP (n = 133 for both), with 20 imputations based on the Markov-chain Monte Carlo technique, using MI IMPUTE to impute the missing values and MI ESTIMATE to analyze the imputed datasets. All analyses were performed using Stata 13 software (StataCorp LP, TX, USA).
RESULTS
Complete BP measurements were available for 719 children at 48 months (Figure 1) . No significant differences in baseline characteristics were seen between those with (n = 719) and without (n = 451) child BP measurements, with the exception of maternal age (P = 0.003) and birth length (P = 0.021; Supplementary Table 4) . Characteristics of subjects included in the study are summarized in Table 1 . Compared with Chinese mothers, Malay mothers tend to be younger, have lower educational attainment, have higher BMI, SBP and DBP (all Po0.01). Child characteristics also differed significantly across the three ethnic groups, including GA at delivery, birth length, SBP and DBP at 48 months (all Po0.05). 12.8% of children (n = 92) had prehypertension/hypertension at age 48 months. Growth velocities for all measures monotonically declined through childhood (Supplementary Table 5 Associations of BMI gain velocities with child BP No significant associations were noted between birth weight-for-GA z-score and child BP at 48 months. After adjusting for potential confounders, faster BMI gain velocities at age 36 to 48 months was (Figures 3d and e) .
Furthermore, no significant interactions between sex, ethnicity or birth weight-for-gestational age with gains in height, BMI, AC or skinfolds were observed during any time interval on later BP.
Associations of growth velocities with child prehypertension/ hypertension No associations were observed between birth anthropometry, height, BMI and adiposity gain at age 0-3 months with prehypertension/hypertension risk at 48-months (Table 2) . Each unit z-score gain in height velocity at 3-12 months, however, was associated with a higher risk of prehypertension/hypertension: OR (95% CI) = 1.45 (1.12, 1.88). Faster gains in BMI and AC velocities during 12-24 months were also associated with a higher risk of prehypertension/hypertension: Sensitivity analyses Similar patterns of association were noted when the analyses were re-ran using age-and sex-specific z-scores for height, BMI, AC, TS and SS across the same intervals for the outcomes of BP Figure 2 . Associations between (a) height gain velocity, (b) body mass index gain velocity, (c) abdominal circumference velocity, (d) triceps skinfolds velocity and (e) subscapular skinfolds velocity with systolic (♦) and diastolic (') blood pressure at age 48 months. All models were adjusted for maternal age, parity, education level, height, BMI, ethnicity, blood pressure, child's age and sex. Growth velocities at later periods were additionally adjusted for growth velocities at preceding intervals, as well as measurement at birth. Models with body mass index, abdominal circumference, triceps and subscapular skinfolds gain velocities were additionally adjusted for child height at age 48 months. **P o0.01; *Po 0.05. Table 6 ), BP z-score (Supplementary Table 7 ) and prehypertension/hypertension (Supplementary Table 8 ). The sensitivity analyses showed that faster BMI and adiposity velocities (AC, TS or SS velocities) at age 36-48 months, but not at earlier intervals in the first 36 months, are predictive of BP and prehypertension/hypertension risk at 48 months.
(Supplementary
DISCUSSION
We found significant associations between timing of BMI and adiposity gains with BP later in childhood. Children who gained BMI and adiposity (AC, TS or SS) at a faster rate than their peers, especially at age 36-48 months, had higher mean BPs and risk of prehypertension/hypertension. These associations remained when BP was analyzed as age-, sex-and height-specific z-scores, suggesting that the observed relationship between BMI and adiposity velocity with child BP is independent of the child's attained height. There have been speculations and hypotheses that early life adiposity gain may exert significant influence on BP later in life. 6 Our results however, add to the evidence that BP is more associated with recent adiposity gain rather than adiposity gain during earlier ages, where we demonstrated that changes in BMI and adiposity at various intervals in the first 36 months were not associated with later BP. In comparison, height gains at all intervals showed no significant associations with BP z-score at age 48 months, suggesting that effects of height gains on later BP may be channeled through final attained height. We also found no evidence of effect modification by sex, ethnicity or birth weight. The stronger effect sizes on BP observed at age 36-48 months is consistent with recent investigations, 7, 10, 14, 28 that showed gains closer to age of BP measurement was a stronger predictor of future BP than were gains in earlier periods. Given that we analyzed growth as rate of change per month across the different periods rather than absolute change, the stronger late effects we observed are not due to the longer period of growth during late infancy and early childhood compared with early infancy.
Our findings are in line with those from cohort studies in Belarus, the United States and the UK. Positive associations between weight gain at ages 3-12 and 12-60 months with child BP at 6.5 years were observed in a cohort of healthy, term children in Belarus, with stronger effect sizes observed during later periods of weight gain closer to 5 years. 10 In Project Viva, an ongoing US birth cohort, BMI gain between 2 and 3 years was found to be associated with higher SBP during mid-childhood (6-10years), with no evidence of effect modification by birth weight.
14 A study of 761 infants in the Southampton Women's Survey reported that greater weight gains between 12-24 and 24-36 months were associated with higher SBP and DBP at 3 years. 9 In addition, Chiolero et al noted that weight gains during any age period after birth have substantial impact on BP during childhood and adolescence, with BP being more responsive to recent compared with earlier weight changes. 28 Positive associations between weight gain at ages 1-5 years, 13 and 2-4 years 29 with adult BP have also been reported. The stronger size of the associations Figure 3 . Associations between (a) height gain velocity, (b) body mass index gain velocity, (c) abdominal circumference velocity, (d) triceps skinfolds velocity and (e) subscapular skinfolds velocity with systolic (♦) and diastolic (') blood pressure z-score at age 48 months. Systolic and diastolic blood pressure z-scores were derived from age-, sex-and height-specific reference values from American Academy of Pediatrics. All models were adjusted for maternal age, parity, education level, height, BMI, ethnicity and blood pressure. Growth velocities at later periods were additionally adjusted for growth velocities at preceding intervals as well as measurement at birth. **P o0.01; *P o0.05.
observed between adiposity velocities and later BP, closer to the age of BP measurement, appear to contrast with Singhal's 'growth acceleration' hypothesis, which found that early infancy weight gain was associated with later BP. 6 Relatively little is known on the role of adiposity gain during infancy and early childhood, on later childhood BP. Higher AC, TS and SS gain at age 36-48 months (which reflect central, peripheral and truncal fat deposition, respectively) were found to be associated with child BP in our cohort. Nowson et al had reported that greater conditional gains in AC and subscapular skinfolds during early childhood were associated with higher BP at 3-years. 9 A recent cross-sectional survey of school children aged 7-17 years in China reported that those with higher skinfold thicknesses had significantly higher BPs than those with lower skinfold thicknesses. 30 Fat mass and waist circumference were also found to be positively and significantly associated with absolute blood pressure and hypertension in a cohort of African-American and European-American children. 31 Fat mass is a strong determinant of BP in both children 32 and adults. 33 Fat distribution as a risk factor for elevated BP is also well-documented, for central, 30, 34 truncal 35 and peripheral fat. 34 The positive relationship between accelerated AC, TS and SS velocities with later BP suggests that additional measurements of AC or skinfolds during childhood may be useful to identify children at risk of elevated BP later in life.
Only one study has investigated the relationship between timing of child growth with later BP explicitly in Asian populations, 12 where the risk of metabolic disease is higher than in Western populations. 15 A longitudinal study of a Hong Kong Chinese cohort reported that growth faltering in ponderal index from 6-18 months was inversely associated with systolic blood pressure in adult life. 12 However, this was attributed to poor nutrition and environmental conditions at the time of the study. Our study findings are consistent with other studies in Western cohorts, as the socioeconomic settings are similar in Singapore.
Strengths of our study include its prospective design, which is essential to assess the relationship between infant and childhood BMI and adiposity velocities with later BP. To date, only one study has explicitly assessed this relationship in Asian populations. Our study also benefited from detailed anthropometric measures at multiple time points, allowing us to elucidate the associations between the timing of infant and early childhood adiposity velocities and later BP. Limitations to consider include the fact that some children in our cohort did not have their 48-month BP measured, although no differences in baseline characteristics were observed between those with and without measured BP. Second, child BP was measured using the Dinamap device, which may have overestimated BP compared with the manual method of measurement. 36, 37 Reference values published by the American Academy of Pediatrics are based on manual BP measurement, 23 and standardization of BP using this reference may therefore have led to an overestimation of BP z-scores and false-positive diagnosis of prehypertension/hypertension. However, as we also analyzed BP as a continuous variable, we expect the relative rank of individual BP measurements to be preserved. Last, our study lacked other cardiovascular risk markers such as plasma insulin, triglyceride and C-peptide, which would be helpful in understanding the associations we observed.
In conclusion, our findings indicate that accelerated BMI and adiposity gains only at the preceding interval before 48 months (age 36-48 months), but not at earlier intervals in the first 36 months, are predictive of BP and prehypertension/hypertension risk at 48 months. Our results add to the evidence that BP is more responsive to recent compared with earlier BMI and adiposity velocities, and provide impetus that measures of adiposity gain may be a useful predictor of elevated BP later in childhood. Interventions that could contribute to the management of accelerated adiposity gain, such as targeting modifiable prenatal factors (for example, gestational weight gain, 38 gestational hyperglycemia 39 ), other dietary changes, or increases in physical activity may be useful to reduce the risks of elevated BP and related cardiovascular outcomes later in life.
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